Đặt banner 324 x 100

Bronchoscopy Market: Growth Drivers, Regional Trends and Forecasts to 2032

The projected global Bronchoscopy Market is anticipated to achieve a valuation of USD 3,174.0 Million by the year 2028, with a compound annual growth rate (CAGR) of 5.5% during the forecast period. This expansion in market size is primarily attributed to the escalating prevalence of respiratory disorders, which encompass infections, passive tobacco smoke inhalation, and air pollution stemming from vehicular emissions. Prominent among these respiratory ailments are asthma and Chronic Obstructive Pulmonary Disease (COPD), both provoked by environmental air pollution. Furthermore, respiratory issues such as pulmonary fibrosis, pneumonia, and lung cancer are also on the rise.
The surge in tobacco consumption, particularly among the youth, has further aggravated the prevalence of respiratory illnesses. The phenomenon of rapid industrialization has led to heightened levels of air pollution, which in turn has fueled the incidence of respiratory disorders and consequently, the demand for bronchoscopy procedures.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/4850
Lung cancer, including both small cell and non-small cell variants, ranks as the second most prevalent form of cancer in both males and females globally. This malignancy predominantly manifests in older individuals, with a significant majority of lung cancer cases occurring among those aged 65 and above. The instances of individuals under 45 being diagnosed with lung cancer are relatively rare.
Lung cancer contributes to approximately a quarter of all cancer-related fatalities. The mortality associated with lung cancer surpasses the combined death tolls of breast, colon, and prostate cancers. This underscores the urgent necessity for bronchoscopy procedures for both diagnosing and treating lung cancer.
The bronchoscopy market is poised for continuous growth over the forecast period due to advancements in bronchoscopy technology and enhancements in medical and healthcare infrastructure. Bronchoscopy remains a pivotal tool for diagnosing and managing lung disorders, especially when immediate intervention is crucial due to disease progression or deteriorating clinical conditions. The ability to distinguish between individuals requiring immediate bronchoscopy intervention and those suitable for delayed treatment is paramount.
Market Dynamics:
Driver: Escalating Air Pollution Air pollution contributes to 9% of global fatalities, varying between 2% and 15% based on the country. Inhalation of air pollutants can lead to airway irritation, resulting in symptoms like breathlessness, wheezing, coughing, asthma exacerbations, and chest discomfort. Prolonged exposure to air pollution can even give rise to lung cancer and, in extreme cases, premature death. The mounting levels of air pollution worldwide will consequently drive the demand for bronchoscopy procedures aimed at treating lung disorders.
Restraint: Scarcity of Expertise and Specialized Pulmonologists The market's growth might be hindered during the forecast period due to the dearth of skilled specialists, the elevated costs associated with bronchoscopy devices, and the risk of device-associated infections linked with reusable bronchoscopes.
To know more about the latest insights of the report, visit @
COVID-19 Analysis: The global healthcare landscape has been significantly disrupted by the COVID-19 pandemic, causing a shift in priorities and resources towards managing severe illnesses. Nonetheless, there has been an increased demand for a range of medical services and products, including bronchoscopy devices such as visualization systems and endoscopes. While bronchoscopy offers diagnostic and therapeutic benefits, it remains an aerosol-generating procedure, which even post-pandemic could pose a risk of COVID-19 exposure and transmission among healthcare personnel, potentially impacting market revenue.
Component Type Insights: The bronchoscopy market is categorized into endoscopes, visualization systems, accessories, and other products. The endoscope segment is projected to exhibit rapid growth during the forecast period. Endoscopes facilitate non-surgical examination of the lungs and airways, obviating the need for anesthesia. This non-invasive approach has spurred demand for endoscopes in the evaluation of respiratory tract disorders.
Usability Insights: The market is segmented into disposable and reusable equipment. The disposable equipment segment is anticipated to witness the highest growth rate. This is attributed to factors like the absence of cross-contamination risk, immediate availability, and cost savings associated with reprocessing.
Patient Type Insights: The segmentation of patient type involves adult and pediatric patients/neonates. The adult patient segment accounted for the majority of revenue in 2020. The escalating adult population, coupled with rising pollution levels and chronic respiratory illnesses, has significantly contributed to the revenue expansion of this segment.
End-Use Insights: The bronchoscopy market is categorized into hospitals, ambulatory surgical centers & clinics, and diagnostic centers. The hospital segment led the market in terms of revenue in 2020. This can be attributed to patients' preference for hospital-based treatments due to advanced equipment availability, skilled medical personnel, robust healthcare infrastructure, and favorable reimbursement policies.
Regional Insights: The North American bronchoscopy market held the largest revenue share in 2020. Factors such as the prevalence of chronic respiratory ailments, favorable reimbursement policies, and the increasing incidence of lung cancer in the US have contributed to North America's dominant market position. The Asia-Pacific market is expected to witness substantial growth due to improving healthcare infrastructure, technological advancements, and a large patient population.
Competitive Landscape: Prominent companies in the global bronchoscopy market include Olympus Corporation (Japan), KARL STORZ (Germany), Fujifilm Holdings Corporation (Japan), Ambu A/S (Denmark), Boston Scientific (US), Medtronic (Ireland), COOK Group Corporation (US), Johnson & Johnson Pvt. Ltd. (US), Hoya Corporation (Japan), and Richard & Wolf GmbH (Germany).
Recent Developments:
  • In September 2020, Olympus Europa introduced the EVIS X1 bronchoscopy system in Europe and MEA, offering advanced solutions for precise diagnosis through improved imaging and tracheobronchial access.
  • In December 2020, Ambu Inc. secured a national single-use endoscopy contract, allowing the company to service about 20% of acute care hospitals in the US, reinforcing its position in the single-use endoscopy domain.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/4850
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  
Browse for more reports:
Polycythemia Vera Market
Testicular Cancer Market
Graves Ophthalmopathy Market
Lung Cancer Market
Chronic Cough Market
Major Depressive Disorder Market
About Reports and Data 
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report